Allergan (NYSE:AGN) is scheduled to announce Q4 earnings results on Monday, February 10th, before market open.
The consensus EPS Estimate is $4.53 (+5.6% Y/Y) and the consensus Revenue Estimate is $4.09B (+0.2% Y/Y).
Over the last 2 years, AGN has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 6 upward revisions and 2 downward. Revenue estimates have seen 7 upward revisions and 2 downward.
https://seekingalpha.com/news/3539881-allergan-q4-2019-earnings-preview
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.